Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Assessment of Efficacy and Safety of Tegaserod Treatment and Placebo in Women With Dyspepsia

NCT00232024 is registered in ClinicalTrials.gov with Novartis as lead sponsor.

NCT NCT00232024
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT00232024 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Assessment of Efficacy and Safety of Tegaserod Treatment and Placebo in Women With Dyspepsia
Lead sponsor
Novartis
Phase
Phase 3
Overall status
Completed
Start date
January 31, 2004
Completion date
May 31, 2006
Enrollment
1,296
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

dyspepsia